Oral COVID treatment yields promising trial data: drugmakers

Pharmaceutical giant Merck and an American laboratory reported promising results Saturday in trials of a drug administered orally to fight COVID-19, saying it helps reduce patients’ viral load. “At a time where there is unmet need for antiviral treatments against SARS-CoV-2, we are encouraged by these preliminary data,” said Wendy…

Vanderbilt collaboration yields promising compound to treat arrhythmia

A collaboration between Vanderbilt University professors of chemistry and medicine yielded a promising compound to treat arrhythmia from an unlikely place: the fungal natural product verticilide. Jeffrey Johnston, Stevenson Professor of Chemistry, said the natural product isn’t active except in insects, but the synthetic mirror-image version – or enantiomer –…